41 – 50 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
(2022) Lund Stem Cell Center Retreat
- Contribution to conference › Poster
-
Mark
Reprogramming primary melanoma cells to dendritic cell fate enhances tumor immunogenicity
(2022) SITC Society for Immunotherapy of Cancer 2022
- Contribution to conference › Poster
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
- Contribution to journal › Published meeting abstract
-
Mark
Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Ontogenic shifts in cellular fate are linked to proteotype changes in lineage-biased hematopoietic progenitor cells
- Contribution to journal › Article
-
Mark
Reprogramming Stars #4 : A Reprogramming Approach for Parkinson's Disease-An Interview with Dr. Malin Parmar
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #3 : Mechanisms of iPSC Reprogramming-An Interview with Dr. Keisuke Kaji
- Contribution to journal › Debate/Note/Editorial
-
Mark
Compositions for reprogramming into dendritic cells type 2 competent for antigen presentation, methods and uses thereof
(2021) WO2021105234
- Patent › Patent
-
Mark
Compositions for reprogramming cells into plasmacytoid dendritic cells or interferon producing cells, methods and uses thereof
(2021) WO2021069672
- Patent › Patent
-
Mark
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
- Contribution to journal › Scientific review
